Creative Biolabs-Immuno-oncology

Anti-DR5 (clone TR2E.2E1G) SynExpress SP-BF-I4-E Modified CD8+ T cells (CAT#: ITS-1224-CR2292)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DR5 (clone TR2E.2E1G). We employs the pGEX (SP6-BFP-IL-4-EcoRI) vector components and the SynExpress system of the Single base pair Insertion/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DR5
Clone
TR2E.2E1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
SP6
Effector Gene
IL-4
Insertion Sites
EcoRI
Gene Modification
Insertion
Modification Domain
Single base pair
Carrier Type
pGEX
Transformation Accuracy
0.89
Cell Culture
Adherent Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.